Table 3. Status of MDM2 amplicon (amplicon A1) and miR-26a-2 amplicon (amplicon A2) as determined by SNP array analysis of 75 human LPS samples.
| Amplicon | Frequency | WD | DD | MRC | P | NOS |
|---|---|---|---|---|---|---|
| Amplicon A1 and A2 | 39 (52%) | 16 | 14 | 6 | 0 | 3 |
| Amplicon A1 only | 5 (7%) | 4 | 0 | 0 | 1 | 0 |
| Amplicon A2 only | 2 (3%) | 1 | 0 | 1 | 0 | 0 |
| No amplicon | 26 (35%) | 6 | 1 | 14 | 2 | 3 |
| Unknown | 3 (4%) | 1 | 0 | 1 | 0 | 1 |
| Total | 75 (101%) |
Abbreviations: DD, dedifferentiated LPS; LOH, loss of heterozygosity; MRC, myxoid/round cell LPS; NOS, not otherwise specified; P, pleomorphic LPS; WD, well-differentiated LPS.